搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
BioPharma Dive
1 小时
Merck antibody reduces RSV-related disease, hospitalizations in trial
Detailed data from a Phase 2b/3 study of Merck’s treatment clesrovimab should support the company’s efforts to win approval by the 2025-2026 season.
BioPharma Dive
1 小时
Gilead withdraws Trodelvy in bladder cancer
The antibody drug conjugate didn’t help patients live longer in a confirmatory trial, prompting a review of its conditional approval.
BioPharma Dive
2 小时
PTC rebuffed again by EMA; Novartis licenses China-based biotech’s cancer drug
European regulators have for the fourth time issued a negative opinion on PTC's Translarna. Elsewhere, Amylyx read out data and Leqembi hit a roadblock in Australia.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Judge unseals new evidence
Preliminary cause of death
Hamas leader Sinwar killed
Bleaching event expands
‘South Pacific' star dies
Sells for $9M at auction
Eases voting rules
Retiring after 15 seasons
Musk's first Trump event
Space export curbs eased
Sued for alleged misconduct
OK classroom Bible suit
TX top court halts execution
Hyundai recalls vehicles
Donations drop 15%
Evidence delay bid denied
US charges ex-Indian spy
Dow closes at record high
Teen anti-sextortion push
‘Full Self-Driving’ probe
Texas AG sues doctor
Colsen fire pits recalled
Nevada US Senate debate
Afghan man denied release
Teen tobacco use falls
988 Lifeline georouting
Files for US IPO
反馈